The Effect Of Rifampicin And Dapsone On Experimental Mycobacterium Leprae Infections: Minimum Inhibitory Concentrations And Bactericidal Action

References

1. Brouet J. H., Modai J., Vergez P. 1969; Essais cliniques de la rifampicine en monotherapie. Etude des taux seriques. Revue Tuberc 33:27
   [Google Scholar]
2. Constans P., Saint-Paul M., Morin Y., Bonnaud G., Bariety M. 1968; Rifampicine: première étude des dosages plasmatiques au cours de traitements prolonges chez des tuberculeux pulmonairés. Revue Tuberc 32:991
   [Google Scholar]
3. Dickinson Jean M., Mitchison D. A. 1966; In vitro studies on the choice of drugs for intermittent chemotherapy of tuberculosis. Tubercle, Lond 47:370
   [Google Scholar]
4. Gaugas J. M. 1967; Antimicrobial therapy of experimental human leprosy (Myco. leprae) infection in the mouse foot pad. Lepr. Rev 38:225
   [Google Scholar]
5. Grumbach F., Rist N. 1967; Activite antituberculeuse experimentale de la rifampicine derive de la rifamycine SV. Revue Tuberc 31:749
   [Google Scholar]
6. Hilson G. R. F., Banerjee D. K., Holmes I. B. 1972 The activity of various antituberculous drugs in suppressing experimental Mycobacterium leprae infection in mice. Int. J. Lepr in press;
   [Google Scholar]
7. Hilson G. R. F., Elek S. D. 1957; Intratesticular multiplication of Mycobacterium lepraemurium in normal and suramin-treated animals. Int. J. Lepr 25:380
   [Google Scholar]
8. Nitti V., Catena E., Bariffi F., Delle Veneri F. 1967; L’attività terapeutica della rifampicina nella tubercolosi polmonare. Arch. Tisiol 22:417
   [Google Scholar]
9. Pallanza R., Arioli V., Furesz S., Bolzoni G. 1967; Rifampicin: a new rifamycin. II Laboratory studies on the antituberculous activity and preliminary clinical observations. Arzneimittel-Forsch 17:529
   [Google Scholar]
10. Porven G., Canetti G. 1968; Les taux de rifampicine dans le serum de l’homme. Revue Tuberc. 32:707
    [Google Scholar]
11. Rees R. J. W. 1965; Recent bacteriologie, immunologie and pathologie studies on experimental human leprosy in the mouse foot pad. Int. J. Lepr 33:646
    [Google Scholar]
12. Rees R. J. W. 1967; Drug resistance of Mycobacterium leprae, particularly to DDS. Int. J. Lepr 35:625
    [Google Scholar]
13. Rees R. J. W., Valentine R. C. 1962; The appearance of dead leprosy bacilli by light and electron microscopy. Int. J. Lepr 30:1
    [Google Scholar]
14. Rees R. J. W., Pearson J. M. H., Waters M. F. R. 1970; Experimental and clinical studies on rifampicin in treatment of leprosy. Br. Med. J 1:89
    [Google Scholar]
15. Shepard C. C. 1960; The experimental disease that follows the injection of human leprosy bacilli into foot-pads of mice. J. Exp. Med 112:445
    [Google Scholar]
16. Shepard C. C. 1967a; A kinetic method for the study of activity of drugs against Mycobacterium leprae in mice. Int. J. Lepr 35:429
    [Google Scholar]
17. Shepard C. C. 1967b; Activity of repository sulfones against Mycobacterium leprae in mice. Proc. Soc. Exp. Biol. Med 124:430
    [Google Scholar]
18. Shepard C. C. 1969a; Further experience with the kinetic method for the study of drugs against Mycobacterium leprae in mice. Activities of DDS, DFD, ethionamide, capreo-mycin and PAM 1392. Int. J. Lepr 37:389
    [Google Scholar]
19. Shepard C. C. 1969b; Minimal effective dosages in mice of clofazimine (B 663) and of ethionamide against Mycobacterium leprae. Proc. Soc. Exp. Biol. Med 132:120
    [Google Scholar]
20. Shepard C. C., Chang Y. T. 1962; Effect of several antileprosy drugs on multiplication of human leprosy bacilli in foot-pads of mice. Proc. Soc. Exp. Biol. Med 109:636
    [Google Scholar]
21. Shepard C. C., Chang Y. T. 1964; Activity of antituberculosis drugs against Mycobacterium leprae. Studies with experimental infection of mouse footpads. Int. J. Lepr 32:260
    [Google Scholar]
22. Shepard C. C., Chang Y. T. 1967; Effect of DDS on established infections with Mycobacterium leprae in mice. Int. J. Lepr 35:52
    [Google Scholar]
23. Shepard C. C., McRae Dorothy H., Habas Janet A. 1966; Sensitivity of Mycobacterium leprae to low levels of 4,4′-diaminodiphenyl sulfone. Proc. Soc. Exp. Biol. Med 122:893
    [Google Scholar]
24. Verbist L., Gyselen A., Cosemans J., Prignot J. 1967; Preliminary results with rifampicin in the retreatment of multiresistant pulmonary tuberculosis in ten salvage cases. Proc. Vth Int. Congr. Chemother. (Vienna) edited by Spitzy K. H., and Haschek H. II/2:591
    [Google Scholar]
25. Waters M. F. R., Rees R. J. W. 1962; Changes in the morphology of Mycobacterium leprae in patients under treatment. Int. J. Lepr 30:266
    [Google Scholar]